MedPath

Measurement of decrease in thickness of diaphragm in patients on artificial ventilation

Phase 3
Recruiting
Conditions
Critically ill patients admitted to the ICU requiring mechanical ventilatory support
Registration Number
CTRI/2017/11/010621
Lead Sponsor
Lakshminarayana Yaddanapudi
Brief Summary

Patients receiving mechanical ventilation in the ICU suffer from diaphragmatic atrophy, which is usually maximal by the third day of ventilation. This atrophy can pose problems in weaning of the patient from ventilation. Synchronised Intermittent Mandatory Ventilation with Pressure Support and Assist-Control Mechanical Ventilation are two comon modes of ventilation in critically ill patients. This study aims to quantify and compare the degree of atrophy with these two modes of ventilation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
42
Inclusion Criteria

Patients requiring mechanical ventilation after admission to ICU.

Exclusion Criteria
  • Mechanical ventilation (invasive and noninvasive) before coming into ICU 2.
  • Patients who are not started on enteral feeding within 24 hours of coming into ICU 3.
  • Patients with known neuromuscular disorders and anatomical malformations of the thorax 4.
  • Patients with neuroparalytic snake bite 5.
  • Patients with organophosphorous compound poisoning 6.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in diaphragmatic thickness measured by ultrasound1st day of ventilation | 3rd day of ventilation (72 hours after the first measurement)
Secondary Outcome Measures
NameTimeMethod
Duration of ventilationAt the time of transfer from the ICU

Trial Locations

Locations (1)

PGIMER

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER
🇮🇳Chandigarh, CHANDIGARH, India
Lakshminarayana Yaddanapudi
Principal investigator
9815836656
narayana.yaddanapudi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.